<?xml version="1.0" encoding="UTF-8"?>
<supplementary-material content-type="local-data" id="tabS4">
 <object-id pub-id-type="doi">10.1128/mSystems.00431-19.10</object-id>
 <label>TABLE S4</label>
 <p>Traditional/lung disease-related objects in the top 10 pathways for ifenprodil (no. 42) and flavopiridol (no. 67) administration. Download 
  <inline-supplementary-material id="tS4" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" xlink:href="mSystems.00431-19-st004.xlsx" content-type="local-data" xmlns:xlink="http://www.w3.org/1999/xlink">Table S4, XLSX file, 0.06 MB</inline-supplementary-material>.
 </p>
 <permissions>
  <copyright-statement>Copyright © 2019 Zhang et al.</copyright-statement>
  <copyright-year>2019</copyright-year>
  <copyright-holder>Zhang et al.</copyright-holder>
  <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xmlns:xlink="http://www.w3.org/1999/xlink">
   <license-p>This content is distributed under the terms of the 
    <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.
   </license-p>
  </license>
 </permissions>
</supplementary-material>
